582 related articles for article (PubMed ID: 28122587)
1. Diseases associated with calcium-sensing receptor.
Vahe C; Benomar K; Espiard S; Coppin L; Jannin A; Odou MF; Vantyghem MC
Orphanet J Rare Dis; 2017 Jan; 12(1):19. PubMed ID: 28122587
[TBL] [Abstract][Full Text] [Related]
2. GENETICS IN ENDOCRINOLOGY: Gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts.
Mayr B; Schnabel D; Dörr HG; Schöfl C
Eur J Endocrinol; 2016 May; 174(5):R189-208. PubMed ID: 26646938
[TBL] [Abstract][Full Text] [Related]
3. Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).
Dong B; Endo I; Ohnishi Y; Kondo T; Hasegawa T; Amizuka N; Kiyonari H; Shioi G; Abe M; Fukumoto S; Matsumoto T
J Bone Miner Res; 2015 Nov; 30(11):1980-93. PubMed ID: 25967373
[TBL] [Abstract][Full Text] [Related]
4. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
[TBL] [Abstract][Full Text] [Related]
5. Diseases associated with the extracellular calcium-sensing receptor.
Thakker RV
Cell Calcium; 2004 Mar; 35(3):275-82. PubMed ID: 15200151
[TBL] [Abstract][Full Text] [Related]
6. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations.
Egbuna OI; Brown EM
Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):129-48. PubMed ID: 18328986
[TBL] [Abstract][Full Text] [Related]
7. Activating Calcium-Sensing Receptor Mutations: Prospects for Future Treatment with Calcilytics.
Mayr B; Glaudo M; Schöfl C
Trends Endocrinol Metab; 2016 Sep; 27(9):643-652. PubMed ID: 27339034
[TBL] [Abstract][Full Text] [Related]
8. Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis.
Hannan FM; Babinsky VN; Thakker RV
J Mol Endocrinol; 2016 Oct; 57(3):R127-42. PubMed ID: 27647839
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
[TBL] [Abstract][Full Text] [Related]
10. Stepwise CaSR, AP2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia.
Szalat A; Shpitzen S; Tsur A; Zalmon Koren I; Shilo S; Tripto-Shkolnik L; Durst R; Leitersdorf E; Meiner V
Endocrine; 2017 Mar; 55(3):741-747. PubMed ID: 28176280
[TBL] [Abstract][Full Text] [Related]
11. Insights into calcium-sensing receptor trafficking and biased signalling by studies of calcium homeostasis.
Gorvin CM
J Mol Endocrinol; 2018 Jul; 61(1):R1-R12. PubMed ID: 29599414
[TBL] [Abstract][Full Text] [Related]
12. Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders.
Nemeth EF; Shoback D
Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):373-84. PubMed ID: 23856266
[TBL] [Abstract][Full Text] [Related]
13. The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases.
Hannan FM; Kallay E; Chang W; Brandi ML; Thakker RV
Nat Rev Endocrinol; 2018 Dec; 15(1):33-51. PubMed ID: 30443043
[TBL] [Abstract][Full Text] [Related]
14. Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia.
Kinoshita Y; Hori M; Taguchi M; Watanabe S; Fukumoto S
J Clin Endocrinol Metab; 2014 Feb; 99(2):E363-8. PubMed ID: 24297799
[TBL] [Abstract][Full Text] [Related]
15. Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene.
Tõke J; Czirják G; Patócs A; Enyedi B; Gergics P; Csákváry V; Enyedi P; Tóth M
Clin Endocrinol (Oxf); 2007 Sep; 67(3):385-92. PubMed ID: 17555508
[TBL] [Abstract][Full Text] [Related]
16. CASR gene activating mutations in two families with autosomal dominant hypocalcemia.
Guarnieri V; Valentina D'Elia A; Baorda F; Pazienza V; Benegiamo G; Stanziale P; Copetti M; Battista C; Grimaldi F; Damante G; Pellegrini F; D'Agruma L; Zelante L; Carella M; Scillitani A
Mol Genet Metab; 2012 Nov; 107(3):548-52. PubMed ID: 22789683
[TBL] [Abstract][Full Text] [Related]
17. Calcium-sensing receptor and associated diseases.
Hendy GN; Guarnieri V; Canaff L
Prog Mol Biol Transl Sci; 2009; 89():31-95. PubMed ID: 20374733
[TBL] [Abstract][Full Text] [Related]
18. Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemia.
Letz S; Haag C; Schulze E; Frank-Raue K; Raue F; Hofner B; Mayr B; Schöfl C
PLoS One; 2014; 9(12):e115178. PubMed ID: 25506941
[TBL] [Abstract][Full Text] [Related]
19. [Disorders Caused by Mutations in Calcium-Sensing Receptor and Related Diseases.].
Michigami T
Clin Calcium; 2017; 27(4):521-527. PubMed ID: 28336828
[TBL] [Abstract][Full Text] [Related]
20. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor].
Watanabe S; Fukumoto S
Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
